The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial

BACKGROUND: N-acetylcysteine (NAC), which is specifically involved in airway mucus clearance and antioxidation, is recommended by the treatment guideline for non-cystic fibrosis bronchiectasis (NCFB). However, there is little clinical evidence of its long-term efficacy concerning quality of life (Qo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yue, Wu, Yanqiu, Zi, Kai, Shen, Yongchun, Wang, Tao, Qin, Jiangyue, Chen, Lei, Chen, Mei, Liu, Lin, Li, Weiming, Zhou, Hui, Xiong, Shuguan, Wen, Fuqiang, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639270/
https://www.ncbi.nlm.nih.gov/pubmed/36344940
http://dx.doi.org/10.1186/s12890-022-02202-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639270/
https://www.ncbi.nlm.nih.gov/pubmed/36344940
http://dx.doi.org/10.1186/s12890-022-02202-9

Ejemplares similares